The common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug’s cholesterol-lowering effects.
Author: neurosciencenews – robotics
Date/time: 11th May 2019, 15:08
Talent Scout, Human Resource Management, Talent Management , Learning & Development, Organizational Development, Change Management, Psychology, Neuropsychology